Menopause affects every woman, yet for decades hormone replacement therapy (HRT) carried a shadow of fear. In this episode, Dr. Manfred Stapff breaks down what the science actually shows and why the FDA's renewed stance on HRT marks a turning point for women's health.

Dr. Manfred cuts through decades of confusion by revisiting the 2002 Women's Health Initiative study that examined older women using outdated hormone formulations. He reveals why those findings never applied to women beginning HRT in their late 40s and 50s and highlights what the evidence actually shows. The risks were minimal, and the relief for symptoms like hot flashes, depression, and night sweats is profound.

He breaks down real-world measures of risk and benefit with clarity, showing how today's low‑dose, bio‑identical, and transdermal therapies offer a far safer profile while meaningfully improving quality of life.

Hear how evidence‑based care can reshape life after menopause. Tune in the full episode of How Hormone Replacement Therapy Can Transform Women's Life After Menopause.

Dr. Manfred Stapff is an entrepreneurial biotech and pharmaceutical expert with deep expertise in real-world evidence and clinical research. As a seasoned leader, he brings decades of experience across all phases of drug development, from opportunity assessment to product launch. His work bridges science and strategy, ensuring medical decisions are grounded in accurate, meaningful data. Dr. Stapff is also an author, committed to promoting evidence-based thinking in medicine. His insights challenge misinformation and advocate for scientific integrity in today's data-driven world.

Connect with Dr. Manfred Stapff, MD:

LinkedIn: https://www.linkedin.com/in/manfredstapff/